Analysis of risk factors for chronic hepatic encephalopathy: The role of Helicobacter pylori infection

American Journal of Gastroenterology

Volumn 93, Issue 5, 1998, Pages 726-731

  Dasani, Bharat M ^a   Sigal, Samuel H ^a   Lieber, Charles S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMOXICILLIN; BILIRUBIN; DIURETIC AGENT; OMEPRAZOLE;

ADULT; ALBUMIN BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MALE; ORAL DRUG ADMINISTRATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR;

AMMONIA; AMOXICILLIN; ANTI-ULCER AGENTS; ASCITES; CHRONIC DISEASE; DIURETICS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROSPECTIVE STUDIES; RISK FACTORS; STOMACH DISEASES;

EID: 0032081008     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.214_a.x     Document Type: Article

References (47)

1. 1. Butterworth RF. The neurobiology of hepatic encephalopathy. Semin Liv Dis 1996;16:235-44.
2. 2. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, nonshunted patients with cirrhosis. J Hepatology 1986;3:75-82.
3. 3. Cordoba J, Blei AT. Treatment of hepatic encephalopathy. Am J Gastroenterol 1997;92:1429-39.
4. 4. Gitlin N. Subclinical portal-systemic encephalopathy. Am J Gastroenterol 1988;83:8-11
5. 5. Phillips GB, Schwartz R, Gabuzda GJ Jr, et al. The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. N Engl J Med 1952;247:239-46.
6. 6. Lieber CS, Lefevre A. Ammonia and intermediary metabolism in hepatic coma: Value of the determination of blood ammonia in the diagnosis and management of cirrhosis. Acta Clinica Belgica 1958; 13:328-57.
7. 7. Rikkers L, Jenko P, Rudman D, et al. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterol 1978;75:462-9.
8. 8. Phear EA, Sherlock S, Summerskill WHJ. Blood-ammonium levels in liver disease and "hepatic coma." Lancet 1955;1:836-40.
9. 9. Summerskill WHJ, Wolpert E. Ammonia metabolism in the gut. Am J Clin Nutr 1970;23:633-9.
10. 10. Kornberg HL, Davies RE. Gastric Urease. Physiol Rev 1955;35:169-77.
11. 11. Walser M, Bodenlos LJ. Urea metabolism in man. J Clin Invest 1957;36:1617-26.
12. 15N-urea. Hum Nutrit Clin Nutrit 1984;38C:339-54.
13. 13. Brown CL, Hill MJ, Richards P. Bacterial ureases in uraemic men. Lancet 1971;2:406-8.
14. 14. Neithercut WD, Rowe PA, El Nujumi AM, et al. Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure. J Clin Pathol 1993;46:544-7.
15. 15. Mokuolu AO, Sigal SH, Lieber CS. Gastric juice urease activity as a diagnostic test for Helicobacter pylori infection. Am J Gastro 1997; 92:644-8.
16. 16. Mossberg SM, Ross G. Ammonia movement in the small intestine: Preferential transport by the ileum. J Clin Invest 1967;46:490-8.
17. 17. Evans WB, Aoyagi T, Summerskill WHJ. Gastrointestinal urease in man, part II: Urea hydrolysis and ammonia absorption in upper and lower gut lumen and the effect of neomycin. Gut 1966;7:635-9.
18. 18. Conn HO. Studies of the source and significance of blood ammonia IV. Early ammonia peaks after ingestion of ammonium salts. Yale J Biol Med 1972;45:543-9.
19. 19. Conn HO. Trailmaking and number connection tests in the assessment of mental state in portal systemic encephalopathy. Dig Dis 1977;22: 541-50.
20. 20. Sood GK, Sarin SK, Mahapatra J, et al. Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: Search for a rational approach. Am J Gastroenterol 1989;84:156-9.
21. 21. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165-71.
22. 22. Gilberstadt SJ, Gilberstadt H, Zieve L, et al. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980;140:519-21.
23. 23. Atherton JC, Cockayne A, Balsitis M, et al. Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine. Gut 1995;36:670-74.
24. 24. Rappoport WJ, Kern F. Gastric urease activity in normal subjects and subjects with cirrhosis. J Lab Clin Med 1963;61:550-9.
25. 25. Fleshler B, Gabuzda GJ. Effect of ammonium chloride and urea infusions on ammonium levels and acidity of gastric juice. Gut 1965; 6:349-56.
26. 26. Lal D, Gorbach SL, Levitan R. Intestinal microflora in patients with alcoholic cirrhosis: Urea-splitting bacteria and neomycin resistance. Gastroenterol 1972;62:275-9.
27. 27. Ito S, Kohli Y, Kato T, et al. Significance of ammonia produced by Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:167-74.
28. 28. Gubbins GP, Moritz TE, Marsano LS, et al. Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: The ammonia hypothesis revisited. Am J Gastroenterol 1993;88:1906-10.
29. 29. Ito S, Miyaji H, Azuma T, et al. Hyperammonaemia and Helicobacter pylori. Lancet 1995;346:124-5.
30. 30. Quero JC, Hartmann IJC, de Rooij F, et al. Hyperammonaemia and Helicobacter pylori. Lancet 1995;346:713-4.
31. 31. Plevris JN, Morgenstern R, Hayes PC, et al. Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet 1995;346:1104.
32. 13C-urea breath test for Helicobacter pylori. Gut 1995;36:337-40.
33. 33. Morgan MH, Read AE, Speller DC. Treatment of hepatic encephalopathy with metronidazole. Gut 1982;12:1-7.
34. 34. Lieber CS, Lefevre A. Ammonia as a source of gastric hypoacidity in patients with uremia. J Clin Invest 1959;38:1271-7.
35. 35. Meyers S, Lieber CS. Reduction of gastric ammonia by ampicillin in normal and azotemic subjects. Gastroenterol 1976;70:244-7.
36. 36. Webster LT Jr, Gabuzda GJ. Relation of azotemia to blood "ammonium" in patients with hepatic cirrhosis. Arch Intern Med 1959;103: 15-22.
37. 37. Lieber CS, Davidson CS. Complications resulting from renal failure in patients with liver disease. Arch Intern Med 1960;106:749-52.
38. 38. Triebling AT, Korsten MA, Dlugosz JW, et al. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig Dis Sci 1991;36:1089-96.
39. 14C-urea in the urea breath test for Helicobacter pylori infection. Scand J Gastroenterol 1993;28:661-6.
40. 40. Baertl JM, Sancetta JM, Gabuzda GJ. Relation of acute potassium depletion to renal ammonium metabolism in patients with cirrhosis. J Clin Invest 1963;42:696-706.
41. 41. Vince AJ, Burridge SM. Ammonia production by intestinal bacteria: The effects of lactose, lactulose and glucose. J Med Microbiol 1980; 13:177-91.
42. 42. Vince A, Down PF, Murison J, et al. Generation of ammonia from non-urea sources in a faecal incubation system. Clin Sci Molec Med 1976;51:313-22.
43. 43. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterol 1977;72:573-83.
44. 44. Weber FL Jr, Banwell JG, Fresard KM, et al. Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: Effects of lactulose and lactulose plus neomycin. J Lab Clin Med 1987;110: 259-63.
45. 45. Kunin CM, Chalmers TC, Leevy CM, et al. Absorption of orally administered neomycin and kanamycin with special reference to patients with severe hepatic and renal disease. N Engl J Med 1960;262: 380-95.
46. 46. Cabre E, Gonzalez-Huix F, Abad-Lacruz A, et al. Effect of total enterai nutrition on the short-term outcome of severely malnourished cirrhotics, a randomized controlled trial. Gastroenterol 1990;98:715-20.
47. 47. Herlong HF, Maddrey WC, Walser M. The use of ornithine salts of branched chain ketoacids in portal systemic encephalopathy. Ann Intern Med 1980;93:545-50.